Cullinan Therapeutics (CGEM) Competitors $6.53 -0.09 (-1.36%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$6.52 -0.01 (-0.15%) As of 09/12/2025 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CGEM vs. EWTX, AUPH, CDTX, PAHC, ARDX, TWST, VERA, AVDL, COGT, and SNDXShould you be buying Cullinan Therapeutics stock or one of its competitors? The main competitors of Cullinan Therapeutics include Edgewise Therapeutics (EWTX), Aurinia Pharmaceuticals (AUPH), Cidara Therapeutics (CDTX), Phibro Animal Health (PAHC), Ardelyx (ARDX), Twist Bioscience (TWST), Vera Therapeutics (VERA), Avadel Pharmaceuticals (AVDL), Cogent Biosciences (COGT), and Syndax Pharmaceuticals (SNDX). These companies are all part of the "pharmaceutical products" industry. Cullinan Therapeutics vs. Its Competitors Edgewise Therapeutics Aurinia Pharmaceuticals Cidara Therapeutics Phibro Animal Health Ardelyx Twist Bioscience Vera Therapeutics Avadel Pharmaceuticals Cogent Biosciences Syndax Pharmaceuticals Edgewise Therapeutics (NASDAQ:EWTX) and Cullinan Therapeutics (NASDAQ:CGEM) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, media sentiment, analyst recommendations, risk, dividends and valuation. Do analysts recommend EWTX or CGEM? Edgewise Therapeutics presently has a consensus target price of $40.55, suggesting a potential upside of 184.73%. Cullinan Therapeutics has a consensus target price of $27.67, suggesting a potential upside of 323.69%. Given Cullinan Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Cullinan Therapeutics is more favorable than Edgewise Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edgewise Therapeutics 0 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.91Cullinan Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, EWTX or CGEM? Edgewise Therapeutics has a beta of 0.26, meaning that its stock price is 74% less volatile than the S&P 500. Comparatively, Cullinan Therapeutics has a beta of -0.08, meaning that its stock price is 108% less volatile than the S&P 500. Does the media prefer EWTX or CGEM? In the previous week, Cullinan Therapeutics had 5 more articles in the media than Edgewise Therapeutics. MarketBeat recorded 11 mentions for Cullinan Therapeutics and 6 mentions for Edgewise Therapeutics. Edgewise Therapeutics' average media sentiment score of 1.70 beat Cullinan Therapeutics' score of 0.71 indicating that Edgewise Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edgewise Therapeutics 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Cullinan Therapeutics 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings and valuation, EWTX or CGEM? Edgewise Therapeutics is trading at a lower price-to-earnings ratio than Cullinan Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEdgewise TherapeuticsN/AN/A-$133.81M-$1.55-9.19Cullinan TherapeuticsN/AN/A-$167.38M-$3.23-2.02 Do institutionals and insiders have more ownership in EWTX or CGEM? 86.3% of Cullinan Therapeutics shares are held by institutional investors. 23.2% of Edgewise Therapeutics shares are held by company insiders. Comparatively, 7.2% of Cullinan Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is EWTX or CGEM more profitable? Edgewise Therapeutics' return on equity of -30.65% beat Cullinan Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Edgewise TherapeuticsN/A -30.65% -29.18% Cullinan Therapeutics N/A -36.56%-34.82% SummaryEdgewise Therapeutics beats Cullinan Therapeutics on 9 of the 14 factors compared between the two stocks. Get Cullinan Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CGEM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CGEM vs. The Competition Export to ExcelMetricCullinan TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$385.75M$3.19B$5.84B$10.14BDividend YieldN/A2.30%5.68%4.60%P/E Ratio-2.0221.4375.4125.98Price / SalesN/A429.44515.81181.13Price / CashN/A46.6837.5660.44Price / Book0.649.6112.156.29Net Income-$167.38M-$53.29M$3.29B$271.07M7 Day Performance-6.58%0.13%0.74%3.87%1 Month Performance-13.85%5.55%5.00%5.49%1 Year Performance-63.62%10.44%62.55%25.86% Cullinan Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CGEMCullinan Therapeutics2.2014 of 5 stars$6.53-1.4%$27.67+323.7%-63.6%$385.75MN/A-2.0230News CoverageAnalyst ForecastEWTXEdgewise Therapeutics2.6371 of 5 stars$14.88-4.4%$40.55+172.5%-24.4%$1.64BN/A-9.6060Positive NewsAUPHAurinia Pharmaceuticals2.9093 of 5 stars$12.30-0.8%$12.00-2.4%+81.2%$1.63B$235.13M28.61300News CoveragePositive NewsCDTXCidara Therapeutics3.147 of 5 stars$62.15-1.6%$64.14+3.2%+449.6%$1.60B$1.27M-5.5890Positive NewsPAHCPhibro Animal Health4.5294 of 5 stars$39.43-0.1%$28.40-28.0%+80.2%$1.60B$1.30B33.422,475Trending NewsInsider TradeAnalyst RevisionARDXArdelyx4.629 of 5 stars$6.59+1.1%$11.70+77.5%+4.8%$1.57B$333.61M-28.6590News CoveragePositive NewsTWSTTwist Bioscience3.9587 of 5 stars$26.25+1.9%$49.40+88.2%-46.1%$1.55B$312.97M-18.10990News CoverageVERAVera Therapeutics2.8827 of 5 stars$24.75+2.3%$63.00+154.5%-36.6%$1.54BN/A-6.9140Positive NewsAVDLAvadel Pharmaceuticals3.0661 of 5 stars$15.38-2.4%$20.86+35.6%+12.4%$1.53B$221.08M-512.6770Positive NewsCOGTCogent Biosciences2.8925 of 5 stars$12.68-2.8%$20.00+57.7%+19.1%$1.49BN/A-7.1280Positive NewsSNDXSyndax Pharmaceuticals3.9115 of 5 stars$16.33-4.2%$38.89+138.1%-18.7%$1.47B$23.68M-4.20110Analyst Forecast Related Companies and Tools Related Companies EWTX Alternatives AUPH Alternatives CDTX Alternatives PAHC Alternatives ARDX Alternatives TWST Alternatives VERA Alternatives AVDL Alternatives COGT Alternatives SNDX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CGEM) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | SponsoredExpert Alert: Massive Bubble Could Crash Your WealthOn July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushin...American Alternative | SponsoredThe End of Elon Musk…?While headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cullinan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cullinan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CGEM Stock Alerts